Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited (STALLION) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Industrial Gases
stallionfluorochemicals.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|
| Sales | 152 Cr | 110 Cr | 106 Cr | 105 Cr |
| Operating expenses (approx.) | 133 Cr | 96 Cr | 90 Cr | 91 Cr |
| EBITDA | 19 Cr | 14 Cr | 16 Cr | 13 Cr |
| OPM % | 12.3% | 12.9% | 14.8% | 12.7% |
| Other income | 2 Cr | 0.07 Cr | 0.19 Cr | 0.23 Cr |
| Interest | 2 Cr | 0.22 Cr | 0.23 Cr | 0.06 Cr |
| Depreciation | 0.29 Cr | 0.29 Cr | 0.29 Cr | 0.30 Cr |
| Profit before tax | 18 Cr | 14 Cr | 15 Cr | 13 Cr |
| Tax % | 27.3% | 25.2% | 25.1% | 15.8% |
| Net profit | 13 Cr | 10 Cr | 11 Cr | 11 Cr |
| EPS (₹) | ₹1.76 | ₹1.31 | ₹1.42 | ₹1.40 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 377 Cr | Sign in for TTM |
| Operating expenses (approx.) | 330 Cr | Sign in for TTM |
| EBITDA | 48 Cr | Sign in for TTM |
| OPM % | 12.6% | Sign in for TTM |
| Other income | 2 Cr | Sign in for TTM |
| Interest | 6 Cr | Sign in for TTM |
| Depreciation | 1 Cr | Sign in for TTM |
| Profit before tax | 42 Cr | Sign in for TTM |
| Tax % | 23.8% | Sign in for TTM |
| Net profit | 32 Cr | Sign in for TTM |
| EPS (₹) | ₹4.98 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 79 Cr |
| Reserves | 222 Cr |
| Borrowings | 2 Cr |
| Other liabilities | 30 Cr |
| Total liabilities | 334 Cr |
| Fixed assets (net) | 17 Cr |
| CWIP | 0.39 Cr |
| Investments | 0 Cr |
| Inventories | 101 Cr |
| Trade receivables | 106 Cr |
| Cash & bank | 59 Cr |
| Other assets | 51 Cr |
| Total assets | 334 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | -13 Cr |
| Cash from investing | -20 Cr |
| Cash from financing | 76 Cr |
| Net cash flow | 43 Cr |
| Free cash flow (OCF − Capex) | -18 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 16.0% |
| ROE % | 10.7% |
| Debtor days | 102 |
| Inventory days | 125 |
| Days payable | 26 |
| Cash conversion cycle | 201 |
| Debt / equity | 0.0081 |
| Current ratio | 9.45 |
| Net debt / EBITDA | -1.18 |
Compare with peers
Loading peers…